Artelo Biosciences (NASDAQ: ARTL) reported Q4 2023 earnings per share (EPS) of -$0.99, up 16.1% year over year. Total Artelo Biosciences earnings for the quarter were -$3.07 million. In the same quarter last year, Artelo Biosciences's earnings per share (EPS) was -$1.18.
As of Q1 2024, Artelo Biosciences's earnings has grown year over year. Artelo Biosciences's earnings in the past year totalled -$9.29 million.
What is ARTL's earnings date?
Artelo Biosciences's earnings date is Invalid Date. Add ARTL to your watchlist to be reminded of ARTL's next earnings announcement.
What was ARTL's revenue last quarter?
Artelo Biosciences (NASDAQ: ARTL) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Artelo Biosciences's revenue was $0.00.
What was ARTL's revenue growth in the past year?
As of Q1 2024, Artelo Biosciences's revenue has grown null year over year. Artelo Biosciences's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.